Product Reports Resources Pricing Login Book a demo

Robocath

Biotech & Life Sciences · Rouen, France · Founded 2009

Innovative solutions for the treatment of cardiovascular diseases MoreLess

Robocath is a medical technology startup that specializes in the development of robotic solutions for the treatment of vascular diseases such as heart attacks and strokes. Their primary product, R-One+, is a robotic unit designed to assist with Percutaneous Coronary Intervention (PCI), a procedure used to treat coronary artery diseases. The R-One+ robot is capable of accurately replicating hand movements, enhancing the precision and effectiveness of medical procedures.

The company's robotic unit optimizes the placement of balloons and stents, two key components in PCI procedures. The robot's guidewire locking system ensures secure access to the lesion throughout the procedure, enhancing the safety and reliability of the treatment. The R-One+ has received positive feedback from healthcare professionals for its exceptional precision and ease of use.

Robocath operates in the healthcare market, specifically in the field of interventional cardiology. Their clients are primarily healthcare professionals and institutions that perform PCI procedures. The company's business model revolves around the development, production, and sale of their robotic units to these healthcare providers. They generate revenue through the sales of their robotic units and potentially through ongoing service and maintenance contracts.

In summary, Robocath is a promising startup in the medical technology sector, offering innovative robotic solutions that enhance the precision and safety of vascular disease treatments.

Keywords: Robocath, medical technology, robotic solutions, vascular diseases, Percutaneous Coronary Intervention, coronary artery diseases, healthcare market, interventional cardiology, R-One+, guidewire locking system.

Company overview

Robocath company information

The essential company record, classifications and operating signals in one place.

Status
Acquired
Founded
2009
Headquarters
Rouen, France
Employees
59
Open positions
None listed
Dealroom signal
64.5
sub industryBioTechnologysub industryMedical Devicesbusiness modelManufacturingindustryHealthsectorBiotechnologysectorSurgerysectorCardiology and cardiovascularsectorNon-Invasive medical devices and treatmentssectorMedical RobotssectorSurgical EquipmentsectorTech for Hospitals and ClinicssectorCollaborative RobotssectorPhysician Support ToolssectorTreatment Assistance

Valuation & funding

Robocath funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Apr 2026 $20M Stereotaxis
DEBTDebt Dec 2021 $17M European Investment Bank
SERIES COther financing Apr 2020 $44M $176M Silk Road Fund · MicroPort · Anaxago · CS Group
SERIES COther financing Sep 2019 $5.5M $22M GO Capital · Normandie Capital Investissement
EARLY VCOther financing Dec 2017 $495K $2M Cardio Participation
EARLY VCOther financing Dec 2017 Supernova Invest
EARLY VCOther financing May 2017 M Capital Partners · GO Capital · Normandie Participations · Normandie Capital Investissement
SUPPORT PROGRAMOther financing Jan 2009 Normandie Incubation
Showing 8 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthEBITDAMargin
2026 $956K 0% −$913K -95.5%
2025 $956K 0% −$913K -95.5%
2024 $956K 0% −$913K -95.5%
2023 $956K +9.9% −$913K -95.5%
2022 $870K +14.5% −$913K -104.9%
2021 $760K +37.7% −$913K -120.1%
2020 $552K −$913K -165.4%
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Robocath website traffic

Latest recorded traffic for Robocath is 830 monthly website visits, down 65.4% over the last three months. Robocath's team declined 4.8% over the past year.

Latest monthly visits830 3-month web change-65.4% 1-year team growth-4.8%
Monthly website visits115 observations · Nov 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Robocath compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Quantum SurgicalDemocratizes minimally invasive cancer treatment through preplanning, advanced robotic assistance, and tumor ablation confirmation Montpellier, France Operational 135 $46M $176M
eCential RoboticsDesigned the first all-in-one surgical platform combining 2D Fluoroscopy, 3D Imaging, and real-time navigation Gières, France Acquired
Ganymed RoboticsGanymed retools orthopaedics with robotics. Their product is a compact, ergonomic, and cost-effective joint-replacement device. The robot's intelligence and perception are driven by computer vision Paris, France Operational
SpinEM RoboticsDeveloping a surgical robot for minimally invasive spinal surgery based on an innovative tracking system Saint-Martin-d'Hères, France Operational
Extremis Roboticsspecializing in research and development of a medical device in the field of surgical robotics of the foot Saint-Martin-d'Hères, France Operational
Moon SurgicalMoon Surgical, formerly kown as MastOR, aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics Paris, France Operational
Medineering GmbHDevelops, manufactures and markets an application-specific and convenient medical robotic portfolio Munich, Germany Acquired
RobeautéWe are developing a sub millimetric microrobot that moves in the brain in curved lines (3D) with sub millimetric precision allowing to access complex areas of the brain in multiple locations to gather data and deliver cargos (micro-electrodes, drugs) Paris, France Operational
Showing 8 of the closest matchesCompare every metric →

Talent graph

Robocath's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

13 investors on Robocath's cap table

Sourced from Dealroom's funding and investor records.

Series A 6 investors entered at this stage
Normandie Participations
M Capital Partners
GO Capital
Normandie Capital Investissement
Cardio Participation
Supernova Invest
Series B+ 5 investors entered at this stage
Silk Road Fund
MicroPort
Anaxago
CS Group
European Investment Bank
Other known 2 additional known investors
Normandie Incubation
Stereotaxis

Global footprint

Where Robocath has talent and traffic

Workforce by country
1 countries with
team presence
🇫🇷 France100%
1 country shown

In the news

Latest news about Robocath

Recent press, funding announcements, and product moves mentioning Robocath — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Robocath

An AI-synthesized read of the highest-engagement posts about Robocath on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Robocath’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.